Literature DB >> 18406622

Review of squamous premalignant vulvar lesions.

H P van de Nieuwenhof1, I A M van der Avoort, J A de Hullu.   

Abstract

Vulvar squamous cell carcinoma (SCC) develops following two different pathways, which have their own premalignant lesions. In the absence of human papilloma virus (HPV), vulvar SCC can develop in a background of lichen sclerosus (LS), differentiated vulvar intraepithelial neoplasia (VIN) or both. The other pathway leading to vulvar SCC is associated with HPV and the HPV-associated premalignancy is usual VIN. In this review we will discuss the history, epidemiology, aetiology, histology, clinical characteristics, treatment options, malignant potential and prevention strategies of the three squamous premalignant vulvar lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18406622     DOI: 10.1016/j.critrevonc.2008.02.012

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  31 in total

Review 1.  Vulvar cancer: a review for dermatologists.

Authors:  Anastasiya Atanasova Chokoeva; Georgi Tchernev; Elena Castelli; Elisabetta Orlando; Shyam B Verma; Markus Grebe; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2015-05-01

Review 2.  [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].

Authors:  L-C Horn; C E Brambs; R Handzel; G Mehlhorn; D Schmidt; K Schierle
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

Review 3.  [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology].

Authors:  L-C Horn; K Klostermann; S Hautmann; A K Höhn; M W Beckmann; G Mehlhorn
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

4.  Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer.

Authors:  Shikha Suman; Ashutosh Mishra
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

5.  Small-area analysis of incidence and localisation of vulvar cancer.

Authors:  Klaus H Baumann; Olga Müller; Helke B Naujok; Ellen Mann; Peter Barth; Uwe Wagner
Journal:  J Oncol       Date:  2010-06-22       Impact factor: 4.375

6.  [Pathoanatomical preparation and reporting of specimens from precancerous lesions and carcinomas of the vulva].

Authors:  L-C Horn; K Schierle; K Klostermann; H-G Schnürch; P Hantschmann
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 7.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

Review 8.  Squamous precursor lesions of the vulva: current classification and diagnostic challenges.

Authors:  Lien N Hoang; Kay J Park; Robert A Soslow; Rajmohan Murali
Journal:  Pathology       Date:  2016-04-23       Impact factor: 5.306

9.  Squamous Cell Carcinoma in a Transgender Man's Neo-Urethra after Metoidioplasty.

Authors:  Maria J D'Amico; Eric Kirshenbaum; Chris M Gonzalez
Journal:  Curr Urol       Date:  2020-12-18

10.  Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions.

Authors:  Melanie Rijsbergen; Rianne Rijneveld; Marina Todd; Gary L Feiss; Stijn T P Kouwenhoven; Koen D Quint; Dirk C J G van Alewijk; Maurits N C de Koning; Erica S Klaassen; Jacobus Burggraaf; Robert Rissmann; Mariëtte I E van Poelgeest
Journal:  Br J Clin Pharmacol       Date:  2020-09-28       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.